Abstract:OBJECTIVETo produce a new bone tissue engineered carrier through combination of xenograft bone (X) and sodium alginate (A) and to investigate the biological character of the cells in the carrier and the ability of bone-forming in vivo, so as to provide experimental evidence for a more effective carrier.METHODSBMSCs were extracted from 2-week-old New Zealand rabbits and the BMSCs were induced by rhBMP-2 (1 x 10(-8)mol/L). The second generation of the induced BMSCs was combined with 1% (V/W) A by final concentration of 1 x 10(5)/mL. After 4-day culture, cells in gel were investigated by HE staining. The second generation of the induced BMSCs was divided into the DMEM gel group and the DMEM containing 1% A group. They were seeded into 48 well-cultivated cell clusters by final concentration of 1 x 10(5)/mL. Seven days later, the BMP-2 expressions of BMSCs in A and in commonly-cultivated cells were compared. The second generation of the induced BMSCs was mixed with 2% A DMEM at a final concentration of 1 x 10(10)/mL. Then it was compounded with the no antigen X under negative pressure. After 4 days, cells growth was observed under SEM. Twenty-four nude mice were randomly divided into 2 groups (n = 12). The compound of BMSCs-A-X (experimental group) and BMSCs-X (control group) with BMSCs whose final concentration was 1 x 10(10)/mL was implanted in muscles of nude mice. Bone formation of the compound was histologically evaluated by Image Analysis System 2 and 4 weeks after the operation, respectively.RESULTSCells suspended in A and grew plump. Cell division and nuclear fission were found. Under the microscope, normal proliferation, many forming processes, larger nucleus, clear nucleolus and more nuclear fission could be seen. BMP-2 expression in the DMEM gel group was 44.10% +/- 3.02% and in the DMEM containing 1% A group was 42.40% +/- 4.83%. There was no statistically significant difference between the two groups (P > 0.05). A was compounded evenly in the micropore of X and cells suspended in A 3-dimensionally with matrix secretion. At 2 weeks after the implantation, according to Image Analysis System, the compound of BMSCs-A-X was 5.26% +/- 0.24% of the total area and the cartilage-like tissue was 7.31% +/- 0.32% in the experimental group; the compound of BMSCs-X was 2.16% +/- 0.22% of the total area and the cartilage-like tissue was 2.31% +/- 0.21% in the control group. There was statistically significant difference between the two groups (P < 0.05). At 4 weeks after the operation, the compound of BMSCs-A-X was 7.26% +/- 0.26% of the total area and the cartilage-like tissue was 9.31% +/- 0.31% in the experimental group; the compound of BMSCs-X was 2.26% +/- 0.28% of the total area and the cartilage-like tissue was 3.31% +/- 0.26% in the control group. There was statistically significant difference between the two groups (P < 0.05).CONCLUSIONThe new carrier compounding A and no antigen X conforms to the superstructural principle of tissue engineering, with maximum cells load. BMSCs behave well in the compound carrier with efficient bone formation in vivo.

A Morphological Study of the Cellular Biocompatability of a New Bone-Matrix Material in Vitro

Cell Biocompatibility of Hydroxyapatite/Silk Fibroin Composite Scaffolds Carrying Bone Morphogenetic Protein

The Comparative Study on the Biocompatibility of Four Kinds of Scaffolds

A Cancellous Bone Matrix System with Specific Mineralisation Degrees for Mesenchymal Stem Cell Differentiation and Bone Regeneration

The Biocompatibility Study of Antigen-Extracted Xenogeneic Cancellous Bone Matrix

Experimental Study on Cultivation and Purification of Bone Marrow-Derived Mesenchymal Stem Cells and Its Co-Culture with Chitosan Porous Scaffolds in Vitro

Celluar compatibilty of the nano-hap/collagen and bone marrow stem cell

Evaluation of human bone marrow stromal cell growth on biodegradable polymer/Bioglass® composites

Biocompatibility of new nano-structured biomimetic bone matrix co-cultured with goat adipose derived stromal cells

In vitro cytotoxicity study of the nano-hydroxyapatite/bacterial cellulose nanocomposites

Comparison of in vitro biocompatibility of NanoBone(®) and BioOss(®) for human osteoblasts

Effect of Mineralized Recombinant Collagen Bone Modified with BMP-2-derived Peptide on Biological Behavior of Bone Marrow Stromal Cells

Cellular compatibility of nano-hydroxyapatite/collagen/calcium aiginate and bone marrow stem cells

[Carrier Combination of Tissue Engineered Bone by Sodium Alginate and Xenograft Bone and Bone Formation in Vivo].

Attachment And Proliferation Of Mouse Bone Marrow Stem Cells On Electrospun Chitosan-Based Nanofibrous Scaffolds

Comparative study on the cellular activities of osteoblast-like cells and new bone formation of anorganic bone mineral coated with tetra-cell adhesion molecules and synthetic cell binding peptide

In Vitro Investigation of Mesenchymal Stem Cells with Nanophase Plga/Ha Composite

Ectopic Osteogenesis and Scaffold Biodegradation of Tissue Engineering Bone Composed of Chitosan and Osteo-Induced Bone Marrow Mesenchymal Stem Cells in Vivo

In Vitro Cytotoxicity of Bacterial Cellulose Scaffolds Used for Tissue-engineered Bone

Studies on Bone Marrow Stromal Cells Affinity of Poly (3-Hydroxybutyrate-co-3-hydroxyhexanoate)

A Clinical and Histological Study of Bio-Oss in Combination with Guided Bone Regeneration Membrane Technique